Enanta Pharmaceuticals
ENTA
#7611
Rank
NZ$0.65 B
Marketcap
NZ$22.58
Share price
-3.50%
Change (1 day)
55.68%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2025 (TTM): NZ-$6.63

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$6.40. In 2024 the company made an earnings per share (EPS) of NZ-$8.27.

EPS history for Enanta Pharmaceuticals from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.63-19.88%
2024NZ-$8.27
2021NZ-$8.3272.92%
2020NZ-$4.81-267.44%
2019NZ$2.87-61.35%
2018NZ$7.44147.22%
2017NZ$3.01-460%
2016NZ-$0.84-114.88%
2015NZ$5.61-23.81%
2014NZ$7.37-244.12%
2013NZ-$5.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.61-390.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.30-292.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$4.00-162.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$23.95-474.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.21-290.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$4.96-177.55%๐Ÿ‡บ๐Ÿ‡ธ USA